SCHEMBL7306049

SCHEMBL7306049

N=C(N)N1CCOC(CNC(=O)O)C1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 5/20 0.36
CPN1 P15169 2/20 0.35
CPB2 Q96IY4 2/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 2/20 0.34
CCR3 P51677 1/20 0.34
ACKR3 P25106 2/20 0.33
PPIB P23284 1/20 0.33
LMNA P02545 1/20 0.32
USP2 O75604 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TSHR P16473 1/20 0.32
TPSAB1 Q15661 1/20 0.32
TPSD1 Q9BZJ3 1/20 0.32
TPSG1 Q9NRR2 1/20 0.32
ENPP2 Q13822 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8918034 0.80 F2 (0.38) PDK1ALDH1A1USP2SMN1; SMN2TSHR
SCHEMBL21813316 0.75 ACKR3 (0.51) KDM4EALDH1A1ACKR3TSHR
Hydrochloric Acid SCHEMBL7396008 0.74 PDK1 (0.41) PDK1CPN1CPB2LMNA
Trifluoroacetic Acid SCHEMBL7293334 0.74 DPP8 (0.34) PDK1CPN1CPB2
SCHEMBL1542957 0.72 F2 (0.48) CPN1CPB2KDM4EALDH1A1TPSAB1
SCHEMBL28629541 0.72 KDM4E (0.41) PDK1KDM4EALDH1A1ACKR3LMNA
SCHEMBL28629542 0.72 KDM4E (0.41) PDK1KDM4EALDH1A1ACKR3LMNA
SCHEMBL20752420 0.71 PDK1 (0.58) PDK1CPN1CPB2LMNA
SCHEMBL24158828 0.71 PDK1 (0.63) PDK1
SCHEMBL8575864 0.71 PDK1 (0.38) PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0559046-B1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors HOFFMANN LA ROCHE (CH) 2001-07-11 EP disclosed
EP-0559046-A1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1993-09-08 EP disclosed